- Delivering Pan India
Cytoblastin® (Vinblastine Sulphate) Vinblastine Sulphate 10 mg/10 mL injection by Cipla. Genuine stock supplied in bulk/wholesale quantities to hospitals and pharmacies across India by A.K. Pharma, a licensed pharmaceutical distributor in Delhi.
| Composition | Vinblastine Sulphate 10 mg/10 mL |
|---|---|
| Manufacturer | Cipla |
| Country | India |
| Pack size | Vinblastine Sulphate 10 mg/10 mL: 1 vial (10 mL) |
| Storage | Store in original pack as per carton instructions |
Supplied only against a valid prescription from a registered medical practitioner.
Sourced from authorised channels
Temperature-controlled packing
Hospitals, clinics, pharmacies
Delhi drug licence holder
Cytoblastin® (Vinblastine Sulphate) Vinblastine Sulphate 10 mg/10 mL Injection — Vinca Alkaloid Cytotoxic Injection: A Sourcing Guide for Hospitals and Oncology Pharmacies
Cytoblastin® is a brand of vinblastine sulphate (sulfate) injection, a vinca alkaloid cytotoxic agent, marketed by Cipla. According to the US prescribing information for vinblastine sulfate injection, it is indicated in the palliative treatment of several malignancies, including generalised Hodgkin’s disease, lymphocytic and histiocytic lymphoma, advanced mycosis fungoides, advanced carcinoma of the testis, Kaposi’s sarcoma and Letterer-Siwe disease. Indications for Cytoblastin in India are defined by its approved pack insert and the Indian regulator. The decision to prescribe vinblastine sulphate, including patient selection, dose and monitoring, rests entirely with the treating physician. This page provides sourcing and procurement information for hospitals and pharmacies, not clinical or treatment guidance.
As both a trusted medicine distributor in Delhi and a licensed pharmaceutical distributor in Delhi, A.K. Pharma supplies genuine Cytoblastin® (vinblastine sulphate) Vinblastine Sulphate 10 mg/10 mL injection to hospitals, oncology centres and pharmacies across India. Buyers comparing pharmaceutical distribution companies and wholesale pharmaceutical distributors can also browse our full product range and the cancer medicines category. Supply is in bulk/wholesale quantities only.
Cytoblastin contains vinblastine sulphate as an aqueous solution for intravenous use only. The carton states 10 mg in 10 mL.
How it works, according to the label: The US label describes vinblastine as an alkaloid extracted from the periwinkle plant (Vinca rosea) and as a stathmokinetic oncolytic agent, meaning it arrests dividing cells in metaphase.
The current US prescribing information for vinblastine sulfate injection (DailyMed) lists the following. Indications in India may differ and are defined by the Indian regulator and the Cytoblastin pack insert.
Vinblastine is a long-established cytotoxic agent. Its labelled uses are described in the prescribing information, which describes it as palliative treatment. Evidence is cited for information only and is not a recommendation for any patient; the approved prescribing information governs.
| Strength | Dosage form | Pack size (as shown on the carton) |
|---|---|---|
| Vinblastine Sulphate 10 mg/10 mL | Aqueous solution for I.V. injection | 1 vial (10 mL) |
Please confirm the current pack and batch with us before ordering. Dose and regimen must be determined and followed exactly as directed by the treating physician and the approved prescribing information.
This page is written for hospital pharmacists, oncology and haematology department buyers, and pharmacies that source cytotoxic injectables. The US label states the preparation should be administered by individuals experienced in the administration of vinblastine.
The US label carries the warning fatal if given by other routes, meaning it is for intravenous use only, and describes serious harm from inadvertent intrathecal administration. It also warns that leakage into surrounding tissue during intravenous administration may cause considerable irritation, and reports aspermia and impaired fertility. This list is not complete; the full prescribing information governs.
All use should follow the approved prescribing information and the instructions of the treating physician.
Please follow the storage instructions printed on the Cytoblastin carton and leaflet. For reference, the US label for vinblastine states storage in a refrigerator at 2°C to 8°C, protected from light, with the vial retained in its carton until use. Hospitals should follow their own cytotoxic-drug handling policies.
Cytoblastin is marketed by Cipla. A.K. Pharma is a licensed distributor and does not manufacture the product. As one of the pharmaceutical distributors serving Indian hospitals, we source Cytoblastin through authorised channels and supply it with pack and batch details. Buyers comparing a pharmaceutical wholesale distributors list or a pharma distribution company can verify our credentials on the About Us page.
Is Cytoblastin available in India?
A.K. Pharma supplies Cytoblastin (vinblastine sulphate) Vinblastine Sulphate 10 mg/10 mL injection to hospitals and pharmacies in India. Contact us for current availability.
What does Cytoblastin contain?
Vinblastine sulphate, a vinca alkaloid, as a 10 mg/10 mL solution for intravenous use only.
Can I order a single pack?
A.K. Pharma is a distributor and supplies bulk/wholesale quantities only, not one or two pieces.
How should Cytoblastin be stored?
As printed on the carton and leaflet. Reference US labels describe refrigerated storage at 2°C to 8°C, protected from light.
Does A.K. Pharma advise on dosing or suitability?
No. Treatment decisions, including dosing, rest solely with the treating physician and the approved prescribing information.
How do I request a quote?
Call or WhatsApp us, or use the contact details below.
📍 E-2/257A, 2nd Floor, Shastri Nagar, New Delhi 110052
📞 011 4172 6999
📱 WhatsApp: +91 9810034827
🌐 akpharma.in
Disclaimer: This page is intended for informational and sourcing/procurement purposes only and does not constitute medical or clinical advice. A.K. Pharma is a licensed medicine distributor, not a healthcare provider, and does not provide clinical guidance. All treatment decisions, including drug selection and dosing, rest solely with the treating physician and should follow the approved prescribing information.
